|
1
|
Tena-Suck ML, Hernández-Campos ME,
Ortiz-Plata A, et al: Intracerebral injection of oil cyst content
of human craniopharyngioma (oil machinery fluid) as a toxic model
in the rat brain. Acta Histochem. 116:448–456. 2014. View Article : Google Scholar
|
|
2
|
Larkin SJ and Ansorge O: Pathology and
pathogenesis of craniopharyngiomas. Pituitary. 16:9–17. 2013.
View Article : Google Scholar
|
|
3
|
Fiorito CM, Giglione E, Bellone S, et al:
Craniopharyngioma in children: importance of a multidisciplinary
approach and therapeutic strategies in the treatment of relapsing.
Minerva Pediatr. 65:673–676. 2013.(In Italian). PubMed/NCBI
|
|
4
|
El-Gaidi MA: Descriptive epidemiology of
pediatric intracranial neoplasms in Egypt. Pediatr Neurosurg.
47:385–395. 2011. View Article : Google Scholar
|
|
5
|
Chakrabarty A, Mitchell P and Bridges LR:
Craniopharyngioma invading the nasal and paranasal spaces, and
presenting as nasal obstruction. Br J Neurosurg. 12:361–363. 1998.
View Article : Google Scholar
|
|
6
|
Bunin GR, Surawicz TS, Witman PA, et al:
The descriptive epidemiology of craniopharyngioma. J Neurosurg.
89:547–551. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ujifuku K, Matsuo T, Takeshita T, et al:
Malignant transformation of craniopharyngioma associated with
moyamoya syndrome. Neurol Med Chir (Tokyo). 50:599–603. 2010.
View Article : Google Scholar
|
|
8
|
Lauriola L, Doglietto F, Novello M, et al:
De novo malignant craniopharyngioma: case report and literature
review. J Neurooncol. 103:381–386. 2011. View Article : Google Scholar
|
|
9
|
Gao S, Shi X, Wang Y, Qian H and Liu C:
Malignant transformation of craniopharyngioma: case report and
review of the literature. J Neurooncol. 103:719–725. 2011.
View Article : Google Scholar
|
|
10
|
Rath SR, Lee S, Kotecha RS, et al:
Childhood craniopharyngioma: 20-year institutional experience in
Western Australia. J Paediatr Child Health. 49:403–408. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Van Effenterre R and Boch AL:
Craniopharyngioma in adults and children: a study of 122 surgical
cases. J Neurosurg. 97:3–11. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Müller HL: Childhood craniopharyngioma:
treatment strategies and outcomes. Expert Rev Neurother.
14:187–197. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hoffman HJ, De Silva M, Humphreys RP, et
al: Aggressive surgical management of craniopharyngiomas in
children. J Neurosurg. 76:47–52. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ogawa Y, Watanabe M and Tominaga T:
Rathke’s cleft cysts with significant squamous metaplasia - high
risk of postoperative deterioration and close origins to
craniopharyngioma. Acta Neurochir (Wien). 155:1069–1075. 2013.
View Article : Google Scholar
|
|
15
|
Yang I, Sughrue ME, Rutkowski MJ, et al:
Craniopharyngioma: a comparison of tumor control with various
treatment strategies. Neurosurg Focus. 28:E52010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Janzer RC, Burger PC, Giangaspero F and
Paulus W: Craniopharyngioma. World Health Organization
Classification of Tumours of the Central Nervous System. Kleihues P
and Cavenee WK: IARC Press; Lyon: pp. 244–246. 2000
|
|
17
|
Carmel PW, Antunes JL and Chang CH:
Craniopharyngiomas in children. Neurosurgery. 11:382–389. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goodrich JT, Post KD and Duffy P: Ciliated
craniopharyngioma. Surg Neurol. 24:105–111. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garcia-Lavandeira M, Saez C,
Diaz-Rodriguez E, et al: Craniopharyngiomas express embryonic stem
cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells
but do not coexpress RET/GFRA3 receptors. J Clin Endocrinol Metab.
97:E80–E87. 2012. View Article : Google Scholar
|
|
20
|
Barkhoudarian G and Laws ER:
Craniopharyngioma: history. Pituitary. 16:1–8. 2013. View Article : Google Scholar
|
|
21
|
Sato K, Oka H, Utsuki S, et al: Ciliated
craniopharyngioma may arise from Rathke cleft cyst. Clin
Neuropathol. 25:25–28. 2006.PubMed/NCBI
|
|
22
|
Zoicas F and Schöfl C: Craniopharyngioma
in adults. Front Endocrinol (Lausanne). 3:462012.
|
|
23
|
Tavangar SM, Larijani B, Mahta A, et al:
Craniopharyngioma: a clinicopathological study of 141 cases. Endocr
Pathol. 15:339–344. 2004. View Article : Google Scholar
|
|
24
|
Crotty TB, Scheithauer BW, Young WF Jr, et
al: Papillary craniopharyngioma: a clinicopathological study of 48
cases. J Neurosurg. 83:206–214. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kawano N, Oka H, Suwa T, et al: Origin of
craniopharyngioma: an electron microscopic study. Noshuyo Byori.
10:117–123. 1993.PubMed/NCBI
|
|
26
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hassounah M, Lach B, Allam A, et al:
Benign tumors from the human nervous system express high levels of
survivin and are resistant to spontaneous and radiation-induced
apoptosis. J Neurooncol. 72:203–208. 2005. View Article : Google Scholar : PubMed/NCBI
|
